NEURONES: Organic growth up 14.7% in 3rd quarter 2022
November 09, 2022 11:40 ET
|
NEURONES
PRESS INFORMATIONHeading: 3rd quarter 2022 revenues Nanterre, November 9, 2022 (after trading) Organic growth up 14.7% in 3rd quarter 2022 (not audited, in € millions)20212022 growth of which...
Innospec Reports Third Quarter 2022 Financial Results
November 08, 2022 16:45 ET
|
Innospec Inc.
All businesses contributing to sales growth of 36 percent and operating income growth of 60 percent Dividend for full year increased by 10 percent; $2.3 million of share repurchases in the quarter ...
Titanium Transportation Group Reports Strong Financial Results; Q3 2022 Revenue of $113 million and Adjusted EBITDA of $15.5 million
November 07, 2022 17:33 ET
|
Titanium Transportation Group Inc
BOLTON, Ontario, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Titanium Transportation Group Inc. ("Titanium" or the "Company") (TSX:TTNM, OTCQX:TTNMF), a leading provider of transportation and logistics...
Lavras Gold’s Third Quarter Marked by Discovery
November 07, 2022 16:45 ET
|
Lavras Gold Corp
The news release should be read in conjunction with our unaudited interim consolidated financial statements and management’s discussion and analysis for the period ended September 30, 2022. Both are...
ARKO Reports Third Quarter 2022 Results
November 07, 2022 16:30 ET
|
ARKO CORP.
RICHMOND, Va., Nov. 07, 2022 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a Fortune 500 company and one of the largest convenience store operators in the United States,...
SmileDirectClub Reports Third Quarter 2022 Financial Results
November 07, 2022 16:01 ET
|
SmileDirectClub, LLC
Disciplined Cost Management Drove Improving Cash FlowRaises Midpoint of 2022 Revenue and Adjusted EBITDA Guidance NASHVILLE, Tenn., Nov. 07, 2022 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq:...
BioNTech veröffentlicht Ergebnisse des dritten Quartals 2022 und Informationen zur Geschäftsentwicklung
November 07, 2022 06:00 ET
|
BioNTech SE
BioNTech und Pfizer bauen mit der Markteinführung des ersten an Omikron BA.4/BA.5 angepassten bivalenten Impfstoffs in mehreren Ländern und Regionen weltweit ihre global führende Position bei...
BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update
November 07, 2022 06:00 ET
|
BioNTech SE
BioNTech and Pfizer continue to build on global COVID-19 vaccine leadership with first-to-market Original/Omicron BA.4/BA.5-adapted bivalent vaccine launches across multiple countries and regions...
eXp World Holdings Reports Record Third Quarter 2022 Revenue of $1.2 Billion
November 02, 2022 06:00 ET
|
eXp World Holdings, Inc.
Q3 2022 Revenue Increased 12% Year over Year to $1.2 Billion With Agent Growth of 30% Company Declares Cash Dividend for Q4 2022 of $0.045 per Share of Common Stock Repurchases Approximately $60...
Kvartalsrapport Q3 2022: Fortsatt stark försäljning, +31% jämfört med motsvarande period föregående år. (MAR)
October 27, 2022 02:00 ET
|
Arcoma AB
2022-10-27 PRESSRELEASE Kvartalsrapport Q3 2022: Fortsatt stark försäljning, +31% jämfört med motsvarande period föregående år. (MAR) FINANSIELLT SAMMANDRAG Tredje kvartalet Totala intäkter för...